259 related articles for article (PubMed ID: 23792283)
1. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations.
Smith SM; Dart RC; Katz NP; Paillard F; Adams EH; Comer SD; Degroot A; Edwards RR; Haddox DJ; Jaffe JH; Jones CM; Kleber HD; Kopecky EA; Markman JD; Montoya ID; O'Brien C; Roland CL; Stanton M; Strain EC; Vorsanger G; Wasan AD; Weiss RD; Turk DC; Dworkin RH
Pain; 2013 Nov; 154(11):2287-2296. PubMed ID: 23792283
[TBL] [Abstract][Full Text] [Related]
2. Clarifying opioid misuse and abuse.
Sullivan M
Pain; 2013 Nov; 154(11):2239-2240. PubMed ID: 23906553
[No Abstract] [Full Text] [Related]
3. Measures That Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: ACTTION Critique and Recommended Considerations.
Smith SM; Jones JK; Katz NP; Roland CL; Setnik B; Trudeau JJ; Wright S; Burke LB; Comer SD; Dart RC; Dionne R; Haddox JD; Jaffe JH; Kopecky EA; Martell BA; Montoya ID; Stanton M; Wasan AD; Turk DC; Dworkin RH
J Pain; 2017 Nov; 18(11):1287-1294. PubMed ID: 28479207
[TBL] [Abstract][Full Text] [Related]
4. Instruments to Identify Prescription Medication Misuse, Abuse, and Related Events in Clinical Trials: An ACTTION Systematic Review.
Smith SM; Paillard F; McKeown A; Burke LB; Edwards RR; Katz NP; Papadopoulos EJ; Rappaport BA; Slagle A; Strain EC; Wasan AD; Turk DC; Dworkin RH
J Pain; 2015 May; 16(5):389-411. PubMed ID: 25660826
[TBL] [Abstract][Full Text] [Related]
5. Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic.
Beauchamp GA; Winstanley EL; Ryan SA; Lyons MS
Am J Public Health; 2014 Nov; 104(11):2023-9. PubMed ID: 25211712
[TBL] [Abstract][Full Text] [Related]
6. Opioid analgesic dose and the risk of misuse, overdose, and death: A narrative review.
Coyle DT; Pratt CY; Ocran-Appiah J; Secora A; Kornegay C; Staffa J
Pharmacoepidemiol Drug Saf; 2018 May; 27(5):464-472. PubMed ID: 29243305
[TBL] [Abstract][Full Text] [Related]
7. Gabapentin misuse, abuse and diversion: a systematic review.
Smith RV; Havens JR; Walsh SL
Addiction; 2016 Jul; 111(7):1160-74. PubMed ID: 27265421
[TBL] [Abstract][Full Text] [Related]
8. THE RISE OF OPIOID ABUSE IN IOWA.
Strickler K
Iowa Med; 2015; 105(3):10-1. PubMed ID: 26591503
[No Abstract] [Full Text] [Related]
9. The effect of an abuse-deterrent opioid formulation (OxyContin) on opioid abuse-related outcomes in the postmarketing setting.
Coplan PM; Chilcoat HD; Butler SF; Sellers EM; Kadakia A; Harikrishnan V; Haddox JD; Dart RC
Clin Pharmacol Ther; 2016 Sep; 100(3):275-86. PubMed ID: 27170195
[TBL] [Abstract][Full Text] [Related]
10. Use and Misuse of Opioids in Chronic Pain.
Volkow N; Benveniste H; McLellan AT
Annu Rev Med; 2018 Jan; 69():451-465. PubMed ID: 29029586
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors for Opioid-Use Disorder and Overdose.
Webster LR
Anesth Analg; 2017 Nov; 125(5):1741-1748. PubMed ID: 29049118
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and correlates of prescription drug diversion and misuse among people living with HIV in the eThekwini district, KwaZulu-Natal, South Africa.
Chibi B; Yende-Zuma N; Mashamba-Thompson TP
PLoS One; 2020; 15(12):e0243718. PubMed ID: 33326499
[TBL] [Abstract][Full Text] [Related]
13. The misuse and abuse of prescription medications: part 1 current trends.
Allread V; Paul S
MD Advis; 2014; 7(4):12-20. PubMed ID: 25485815
[TBL] [Abstract][Full Text] [Related]
14. A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world.
Lofwall MR; Walsh SL
J Addict Med; 2014; 8(5):315-26. PubMed ID: 25221984
[TBL] [Abstract][Full Text] [Related]
15. Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations.
O'Connor AB; Turk DC; Dworkin RH; Katz NP; Colucci R; Haythornthwaite JA; Klein M; O'Brien C; Posner K; Rappaport BA; Reisfield G; Adams EH; Balster RL; Bigelow GE; Burke LB; Comer SD; Cone E; Cowan P; Denisco RA; Farrar JT; Foltin RW; Haddox DJ; Hertz S; Jay GW; Junor R; Kopecky EA; Leiderman DB; McDermott MP; Palmer PP; Raja SN; Rauschkolb C; Rowbotham MC; Sampaio C; Setnik B; Smith SM; Sokolowska M; Stauffer JW; Walsh SL; Zacny JP
Pain; 2013 Nov; 154(11):2324-2334. PubMed ID: 24148704
[TBL] [Abstract][Full Text] [Related]
16. Motives for medical misuse of prescription opioids among adolescents.
McCabe SE; West BT; Boyd CJ
J Pain; 2013 Oct; 14(10):1208-16. PubMed ID: 23954519
[TBL] [Abstract][Full Text] [Related]
17. Frequency of prescription opioid misuse and suicidal ideation, planning, and attempts.
Ashrafioun L; Bishop TM; Conner KR; Pigeon WR
J Psychiatr Res; 2017 Sep; 92():1-7. PubMed ID: 28364579
[TBL] [Abstract][Full Text] [Related]
18. Error and bias in the evaluation of prescription opioid misuse: should the FDA regulate clinical assessment tools?
Meltzer EC; Hall WD; Fins JJ
Pain Med; 2013 Jul; 14(7):982-7. PubMed ID: 23594383
[TBL] [Abstract][Full Text] [Related]
19. Prescription Opioid Misuse, Abuse, Morbidity, and Mortality: Balancing Effective Pain Management and Safety.
Cheatle MD
Pain Med; 2015 Oct; 16 Suppl 1():S3-8. PubMed ID: 26360931
[TBL] [Abstract][Full Text] [Related]
20. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse (Part 2).
Kaye AD; Jones MR; Kaye AM; Ripoll JG; Jones DE; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
Pain Physician; 2017 Feb; 20(2S):S111-S133. PubMed ID: 28226334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
